1 Anti-hypertensive Flashcards
What are the mechanisms involved in controlling BP?
IMPT!
Short term -> Sympathetic Activity (on heart and smooth muscles)
Long term -> RAAS
Name 4 classes of anti-hypertensives
ACE-I , AT1 blockers
Beta blockers
Calcium channel blockers
Diuretics
ACE-I: angiotensin-converting enzyme inhibitors
AT1 blockers: angiotensin II receptor type 1 antagonist
Why do we not prescribe both ACE-I & Angiotensin II receptor type 1 antagonists together?
- Efficacy is not additive (reach saturated stage of block Angiotensin pathway)
- May lead to additive adverse effects e.g. worsen renal function or hyperkalemia more
both work on the same pathway /:
Name 3 ACE-I
Lisinopril, Captopril, Enalapril
MoA of ACE-I
vvv IMPT!
- inhibits ACE enzyme
decreases Angiotensin II formation
- decreases vasoconstriction → decreases peripheral vascular resistance
+
- decreases aldosterone secretion → decrease salt + fluid retention
Hence decreased BP - blocks inactivation of bradykinin (additional effect)
→ increases NO and prostaglandin production
→ increases vasodilation
Hence also decreased BP
see diagram on pg 13
Name 4 clinical uses for ACE-I
- Hypertension
- Cardiac failure (reduce preload and afterload)
- following MI
- Renal insufficiency
Renal insufficiency is poor function of the kidneys that may be due to a reduction in blood-flow to the kidneys caused by renal artery disease.
Name 4 adverse effects of ACE-I.
What is ACE-I contraindicated in?
- severe hypotension
- acute renal failure (due to decrease in aldosterone secretion)
- hyperkalemia (due to decrease in aldosterone secretion)
- angioedema & dry cough (bradykinin & substance P)
contraindication: pregnancy (damage renal function of fetus)
recall aldosterone reabsorb Na+ and water, excretes K+
recall ACE-I decrease Angiontensin II -> decrease aldosterone
recall ACE-I blocks inactivation of bradykinin -> a lot of bradykinin
Name 5 angiotensin II receptor type 1 receptor antagonists
Losartan
Valsartan
Candesartan
Irbesartan
Telmisartan
MoA of (Angiotensin II receptor type 1) AT1 blockers
binds to AT1 receptor and blocks action of Angiotensin II (vasoconstriction, ADH secretion, stimulates thirst, aldosterone production)
→ decrease BP
AT1 receptor receives signal from Angiotensin II but this drug cut queue and block Angiotensin II
Competitive inhibitor
Name 1 adverse effect of (Angiotensin II receptor type 1) AT1 blockers.
What is AT1 blockers contraindicated in?
- Less / no dry cough (as compared to ACE-I)
- Same contraindication: pregnancy
Name 3 (β1, β2) non-selective beta blockers
- Propanolol
- Pindolol
- Carvedilol
blocks β1 and β2 equally well
Name 3 cardioselective β1 blockers
- Atenolol
- Bisoprolol
- Metoprolol
higher affinity for β1 doesn’t mean doesn’t block β2 at all
Name a mixed (3rd generation) beta blocker
Nebivolol
- β1 selective in low dose / fast metabolizers (majority of population)
- Non-selective in high dose/ slow metabolizers
- also has vasodilatory effects through ↑ NO release
MoA of beta blockers in cardiac myocytes
block β1
→ reduce cAMP
→ reduce PK A
→ reduce activation of Ca2+ channel
→ less Ca2+ get into cytosol
→ less Ca2+ release from sarcoplasmic reticulum
→ less activation of actin-myosin complex
→ reduce contractility of cardiac muscles
see diagram on pg 18
Which beta blockers are also approved to treat heart failure?
lower BP + treat heart failure wow
- Carvedilol
- Bisoprolol
- Metoprolol
- Nebivolol